Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Clicks GroupCLCGY -1.00%84 3-1 Month Momentum % is -10.15% as of Aug. 08, 2026. GuruFocus rates CLCGY with a GF Score™ of 84/100 and a GF Value™ of $49.98 (Significantly Undervalued). Among 674 Healthcare Providers & Services companies, Clicks Group ranks worse than 74.93% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-08), Clicks Group's 3-1 Month Momentum % is -10.15%.
The industry rank for Clicks Group's 3-1 Month Momentum % or its related term are showing as below:
CLCGY's 3-1 Month Momentum % is ranked worse than 74.93% of 674
companies
in the Healthcare Providers & Services industry
Industry Median: -2.265
vs CLCGY: -10.15
Clicks Group (OTCPK:CLCGY) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Clicks Group 3-1 Month Momentum % Related Terms
Clicks Group 3-1 Month Momentum % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Clicks Group's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clicks Group 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Clicks Group's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Clicks Group's 3-1 Month Momentum % falls into.
Clicks Group (OTCPK:CLCGY) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clicks Group (CLCGY) has a 3-1 Month Momentum % of -10.15% as of Aug. 08, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Clicks Group and its competitors. According to the industry distribution chart, Clicks Group ranks #505 out of 674 companies in the Healthcare Providers & Services industry, placing it in the top 74.9%.
Is Clicks Group's 3-1 Month Momentum % too high?
Clicks Group's current 3-1 Month Momentum % is -10.15%. Based on the distribution chart, Clicks Group ranks #505 out of 674 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Clicks Group has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Clicks Group's 3-1 Month Momentum % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Clicks Group ranks #505 out of 674 companies for 3-1 Month Momentum %. This places Clicks Group in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
A good 3-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Clicks Group and its competitors. Clicks Group's current 3-1 Month Momentum % is -10.15%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clicks Group stock overvalued right now?
Based on GuruFocus' analysis, Clicks Group (CLCGY) is currently considered Significantly Undervalued. The stock's GF Value™ is $49.98, compared to a current price of $26.72 — trading 46.5% below its estimated fair value. The current 3-1 Month Momentum % is -10.15%. Clicks Group's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Clicks Group (CLCGY), the current 3-1 Month Momentum % is -10.15% as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clicks Group (CLCGY) Overvalued in 2026?
Based on GuruFocus' analysis, Clicks Group stock appears to be undervalued.
The current stock price of $26.72 is trading 46.5% below its estimated GF Value™ of $49.98.
GuruFocus considers Clicks Group to be Significantly Undervalued.
Key valuation signals for CLCGY:
3-1 Month Momentum %: -10.15%
GF Value™: $49.98 vs. price of $26.72 (46.5% below fair value)
No single metric tells the full story. See the CLCGY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clicks Group Ltd operates prominently in health, beauty, and wellness retail across southern Africa. The company predominantly operates a retail pharmacy chain in South Africa, with a limited number of operations in bordering countries. The company has a portfolio of retail franchise brands including The Body Shop, M-Kem, and Sorbet among others. The company's business segments include Retail and Distribution. The company generates revenue from in-store and online sales of health, beauty, and wellness items, plus wholesale pharmaceutical distribution. Geographically, the maximum revenue is generated from South Africa.
84GF Score
Get the complete analysis for CLCGY
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLCGY has been successfully added to your 
